Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

MEDLAB CLINICAL LIMITED

INVESTOR PRESENTATION - MEDLAB CLINICAL LIMITED

ASX:MDC

MEDLAB CLINICAL LIMITED

Health Care

Medlab Clinical is a medical research and development facility researching and formulating novel bio-therapeutics (e.g., nutraceuticals and pharmaceuticals) to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease and pre-diabetes/obesity.

Read more

Market Cap

57.33m

Price at Close

$0.205

4w avg. Volume

381.13k

4w avg. Turnover

$74.27k

Announcements
announcementt+2 movementdate
  • Results of Meeting

    Notice Of Meeting

  • -

    16 Oct 2020

-

16 Oct 2020
  • AGM Presentation

    Chairman's Address

  • -2.38%

    15 Oct 2020

-2.38%

15 Oct 2020
  • Attendance at AGM

    Notice Of Meeting

  • -4.44%

    11 Oct 2020

-4.44%

11 Oct 2020
  • Medlab to Present at Key US Investor Conferences

    Company Administration

  • -2.78%

    30 Sep 2020

-2.78%

30 Sep 2020
  • Australian Patent Granted for NanoCelle Delivery Platform

    Progress Report · Market sensitive

  • +3.03%

    22 Sep 2020

+3.03%

22 Sep 2020
  • NanaBis Investor Presentation

    Periodic Reports

  • +9.09%

    20 Sep 2020

+9.09%

20 Sep 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • -8.11%

    15 Sep 2020

-8.11%

15 Sep 2020
  • Medlab Signs CRO for NanaBis Phase III Trial

    Progress Report

  • -9.68%

    31 Aug 2020

-9.68%

31 Aug 2020
  • Corporate Governance Statement

    Periodic Reports

  • -3.23%

    28 Aug 2020

-3.23%

28 Aug 2020
  • Appendix 4G

    Periodic Reports

  • -3.23%

    28 Aug 2020

-3.23%

28 Aug 2020
Market Data

Current Price

$0.205

52WK HIGH

$0.45

52WK LOW

$0.125

1YR RETURN

-53.93%

1YR RETURN VS. SECTOR

-81.63%

90 DAY RETURN

+41.38%

ASX RANK

1,006

/2,010

SECTOR RANK

26

/47

SHARES OUTSTANDING

279.68m
ASX:MDC

MEDLAB CLINICAL LIMITED

Health Care

Medlab Clinical is a medical research and development facility researching and formulating novel bio-therapeutics (e.g., nutraceuticals and pharmaceuticals) to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease and pre-diabetes/obesity.

Read more

Market Cap

57.33m

Price at Close

$0.205

4w avg. Volume

381.13k

4w avg. Turnover

$74.27k

ASX:MDC is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.